a.cardoso

TL2 · Braga

Contributes reviews on supplier material. Based in Braga.

Joined 18 September 2025 · last posted 2d

83 posts, newest first. Showing up to 150.

Request: a per-category review queue Replied, post #132 · Meta › Feature requests · 26 Jul 2026 · 22 likes Source for the per-category review queue figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #10 · Compounds › Repair & healing peptides · 25 Jul 2026 · 17 likes Narrowing post #7, because the general version has more than one answer. BPC-157: the preclinical literature is extensive, mostly from a small number of research…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #59 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 3 likes What I would check first on Reading a rodent study is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Priming a pen and whether the primed volume is wasted Replied, post #15 · Devices › Pens & autoinjectors · 20 Jul 2026 · 13 likes Priming exists because the needle and the cartridge path contain air after a needle change. Skipping it means the first fraction of the dose is not liquid.
How shortages have affected compounding permissions — does this still hold? Replied, post #28 · Access › Shortages · 19 Jul 2026 · 22 likes I would put moderate confidence on the mainstream reading of shortages and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #46 · Compounds › Secretagogues & GH axis · 17 Jul 2026 · 6 likes Everything in post #44 holds. The case it does not cover is the one I have. A note on scope: what I am saying about GHRH analogues versus ghrelin mimetics applies to…
An 18-month record including the parts that went badly Replied, post #70 · Outcomes › Progress reports · 15 Jul 2026 · 0 likes The arithmetic in post #68 is right; the assumption feeding it is the part to check. Seasonal patterns: some people report weight loss is slower in winter than summer.…
Immortal time bias in a claims-database study — one year on Replied, post #17 · Evidence › Study critique · 11 Jul 2026 · 18 likes Where I would push back on the Immortal time bias consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #59 · Evidence › Journal club · 6 Jul 2026 · 23 likes An honest declaration on STEP 1: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #96 · Sourcing › Vendor reports · 5 Jul 2026 · 0 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #26 · Pharmacology › Receptor biology · 24 Jun 2026 · 19 likes Narrowing post #23, because the general version has more than one answer. Endogenous versus pharmacological receptor engagement differ in magnitude and in duration by…
Follow-up: Sleep quality changes during weight loss Replied, post #37 · Wellbeing › Sleep · 4 Jun 2026 · 0 likes Post #33 put the caveat in the right place and I want to underline it. The published data on sleep outcomes in this class is thinner than the volume of discussion,…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #124 · Compounds › Tirzepatide · 14 May 2026 · 3 likes Post #120 and I disagree about the size of the effect, not about the direction. 2.5 mg starting dose is worth one more sentence than it usually gets, and the sentence…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #53 · Practice › Reconstitution · 14 May 2026 · 13 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #20 · Analytics › Home & field testing · 12 May 2026 · 4 likes Post #19 answers the question as asked. The question underneath it is different. On Lateral-flow and colorimetric approaches: the maintained page in the documentation…
Area percent versus weight percent: the confusion that causes most arguments Replied, post #8 · Analytics › HPLC & UHPLC · 7 May 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
Journal club: is percentage weight change the right endpoint? Replied, post #101 · Evidence › Journal club · 25 Apr 2026 · 0 likes Adding the measurement that post #100 says would settle it. The figures usually contain the finding and the text usually contains the interpretation. Separating them…
Five questions in one post gets you one answer — how to split them Replied, post #62 · Start Here › How to Ask · 23 Apr 2026 · 4 likes Helpful, and easy to find again, which is half of what a good reply is.
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #89 · Compounds › Tirzepatide · 19 Apr 2026 · 0 likes The most useful thing anyone has posted about 2.5 mg starting dose in this category was a table of what had been measured and by whom. That is what I would want again.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #85 · Analytics › Mass spectrometry · 15 Apr 2026 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #33 · Sourcing › Logistics · 4 Apr 2026 · 23 likes Adding the measurement that post #31 says would settle it. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not…
Transporting a vial for a weekend away — a second dataset Replied, post #10 · Practice › Storage & stability · 19 Mar 2026 · 15 likes Picking up post #9: that is the part I would want checked first. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #76 · Compounds › Semaglutide · 9 Mar 2026 · 9 likes A definition problem is doing most of the work in this semaglutide solutions discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #51 · Analytics › Impurities & related substances · 26 Feb 2026 · 7 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #80 · Clinical › Bloodwork · 19 Feb 2026 · 8 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial. I have no…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #46 · Clinical › Special populations · 18 Feb 2026 · 2 likes Where I part company with post #43, and it is a narrow parting. Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that…
Second pass at: Identical chromatograms across two different lots Replied, post #8 · Sourcing › Red flags · 14 Feb 2026 · 18 likes Post #7 and I disagree about the size of the effect, not about the direction. Having read the whole Identical chromatograms thread before replying: the question in the…
Amylin receptor signalling and satiety — what changed since Replied, post #25 · Pharmacology › Receptor biology · 3 Feb 2026 · 3 likes I would put moderate confidence on the mainstream reading of Amylin receptor signalling and satiety and no more. That is not scepticism for its own sake; it is where…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #91 · Clinical › Special populations · 3 Feb 2026 · 31 likes Older adults: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #96 · Clinical › Special populations · 26 Jan 2026 · 3 likes Careful with the language on Pregnancy and pregnancy planning. "Not detected" and "not present" are different findings and the first is a statement about the method.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #10 · Pharmacology › Pharmacokinetics · 7 Jan 2026 · 29 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #5 · Practice › Administration · 1 Jan 2026 · 3 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
Coverage in the US: a map of the usual obstacles Replied, post #26 · Regional › North America · 23 Dec 2025 · 0 likes The arithmetic in post #24 is right; the assumption feeding it is the part to check. I read the earlier replies on coverage twice before writing this, because I had…
DXA precision and the least significant change for lean mass Replied, post #49 · Outcomes › Body composition · 7 Dec 2025 · 3 likes Worth stating the null on DXA precision before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #58 · Practice › Interactions · 28 Nov 2025 · 5 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #15 · Compounds › Other compounds · 22 Nov 2025 · 7 likes Careful with the language on Sequence verification. "Not detected" and "not present" are different findings and the first is a statement about the method.
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #3 · Safety › Contraindications · 10 Nov 2025 · 1 like I had written a reply contradicting the opening post and deleted it. Here is what survived. Nothing here is medical advice, and a contraindication question is one where…
Follow-up: Why appetite effects are mostly central Replied, post #85 · Pharmacology › Receptor biology · 3 Nov 2025 · 1 like The arithmetic in post #82 is right; the assumption feeding it is the part to check. An observation about appetite effects that I cannot explain and am posting anyway,…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #25 · Devices › Pens & autoinjectors · 27 Oct 2025 · 0 likes A pen delivers a fixed or dialled dose from a cartridge and is a metering device rather than simply a covered syringe. That is why dose changes are constrained to…
The anatomy of a question that gets answered within an hour — the long version Replied, post #23 · Start Here › How to Ask · 24 Oct 2025 · 6 likes Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #60 · Compounds › Semaglutide · 18 Sep 2025 · 14 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Coming back to: What published stability data actually covers, and what it does not Replied, post #136 · Practice › Storage & stability · 9 Sep 2025 · 8 likes Appreciated. The plain phrasing does more work here than a longer post would.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #51 · Practice › Reconstitution · 3 Sep 2025 · 13 likes Appreciated. The plain phrasing does more work here than a longer post would.
A request that was declined, and the reasoning — a second dataset Replied, post #61 · Documentation › Wiki requests · 12 Aug 2025 · 0 likes Name a willing maintainer in the request. Point three of the criteria stops more nominations than the other three combined. Old habit: I write down the expected answer…
Pricing far outside the range, in either direction Replied, post #2 · Sourcing › Red flags · 4 Aug 2025 · 5 likes Worth separating two things that the opening post runs together. Testimonials without a lot, a date, a method or a service are not evidence and are not a red flag…
Why oral semaglutide needs an absorption enhancer at all Replied, post #23 · Compounds › Oral incretins · 4 Aug 2025 · 15 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #13 · Analytics › Method validation · 12 Jul 2025 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. Worth one more sentence than it…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #89 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 10 likes This is the answer, and the reason it is the answer is the more useful part.
[2026 update] An appeal that failed, and what I would do differently Replied, post #56 · Access › Insurance & coverage · 10 Jun 2025 · 13 likes The arithmetic in post #53 is right; the assumption feeding it is the part to check. I would keep appeal and the decision it usually gets used for separate in this…
GIP receptor agonism and the argument about direction Started this topic · Pharmacology › Receptor biology · 7 Jun 2025 · 40 likes GIP receptor agonism and the argument about direction — setting out what I have, and where I think it stops being reliable. A question about GIP receptor agonism that I…
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #19 · Clinical › Bloodwork · 28 May 2025 · 15 likes Reframing hba1c lag slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
Counter-ion content and its effect on measured mass Replied, post #44 · Analytics › Mass spectrometry · 21 May 2025 · 2 likes Summarising the counter-ion content thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and…
A report I filed that turned out to be wrong, and the correction Replied, post #60 · Sourcing › Vendor reports · 19 May 2025 · 3 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #2 · marked as the solution · Evidence › Journal club · 10 May 2025 · 25 likes CagriSema phase 2 combination paper is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Water content on a certificate and why it changes the arithmetic Replied, post #15 · Analytics › COA interpretation · 7 May 2025 · 23 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #105 · Evidence › Journal club · 22 Apr 2025 · 4 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #8 · Clinical › Bloodwork · 18 Apr 2025 · 1 like I read post #6 twice before replying, because I had assumed the opposite. Building a sensible monitoring schedule would be much easier to settle if anyone reported the…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 7 Apr 2025 · 2 likes Marking my place. If it changes for me I will come back and say so.
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #75 · Devices › Cold chain · 28 Mar 2025 · 0 likes On Domestic fridge temperature mapping the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #53 · Sourcing › Vendor reports · 16 Mar 2025 · 32 likes Adding a data point of agreement rather than a data point.
Retatrutide dose escalation in the published trials Replied, post #14 · Compounds › Retatrutide · 14 Mar 2025 · 7 likes What I would check first on retatrutide dose escalation is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
Ipamorelin selectivity claims and where they came from Replied, post #20 · Compounds › Secretagogues & GH axis · 14 Mar 2025 · 19 likes I had written a reply contradicting post #18 and deleted it. Here is what survived. On analysis: these are short peptides and generally straightforward…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #50 · Practice › Reconstitution · 9 Mar 2025 · 0 likes Answering the question post #48 raises rather than the one it answers. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
When "no data" is the complete and final answer Replied, post #106 · Compounds › Other compounds · 1 Mar 2025 · 16 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Reading an MS report that only gives you a single number Replied, post #8 · Analytics › Mass spectrometry · 10 Feb 2025 · 0 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
A promotion I argued against, and why I lost Replied, post #66 · Documentation › Doc review · 18 Jan 2025 · 1 like Understood. Thank you for being specific about the limits of it.
Oxidation pathways for methionine and tryptophan Replied, post #41 · Analytics › Impurities & related substances · 29 Dec 2024 · 12 likes If you are new and reading this thread for the answer to oxidation pathways for methionine: the answer is conditional, the conditions are in the third reply, and the…
Reading a supplementary appendix and finding the interesting part Replied, post #52 · Evidence › Trials · 26 Dec 2024 · 1 like Nobody has said the unglamorous part of reading a supplementary appendix yet, so: most of the variation is explained by things that are boring to write about and easy…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #22 · Compounds › Semaglutide · 20 Dec 2024 · 10 likes Agreed, and I will stop repeating the version of this I had been repeating.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #44 · Access › Insurance & coverage · 27 Nov 2024 · 8 likes This follows post #43 rather than contradicting it. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #39 · Clinical › Special populations · 22 Nov 2024 · 23 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question. I…
Follow-up: What this community means by "a source", in practical terms Replied, post #14 · Start Here › Welcome · 22 Nov 2024 · 10 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #85 · Clinical › Prescriber conversations · 25 Oct 2024 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #68 · Compounds › Other compounds · 23 Oct 2024 · 0 likes Before the thread moves on from Melanocortin agonists — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #20 · Clinical › Comorbidities · 11 Oct 2024 · 22 likes This follows post #17 rather than contradicting it. Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than…
Requesting a page: what makes a good request — what changed since Replied, post #26 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes On post #24 — agreed on the reasoning, with one qualification. Whatever the answer on Requesting a page turns out to be, the method for getting there is the same: state…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #12 · Practice › Administration · 6 Sep 2024 · 2 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Second pass at: Reimbursement variation across member states Replied, post #3 · Regional › European Union · 23 Aug 2024 · 5 likes This follows post #2 rather than contradicting it. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management…
Guidelines revision: what changed and why Replied, post #24 · Meta › Announcements · 25 Jul 2024 · 0 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. Thank you for announcing it in advance rather than after. The…
Circumference measurements as a poor man's composition estimate Replied, post #17 · Outcomes › Body composition · 24 Jul 2024 · 21 likes Nothing here is medical advice and none of these measurements is diagnostic on its own.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #76 · Practice › Dosing & titration · 9 Jul 2024 · 11 likes Post #73 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…
Journal club: FLOW and the renal composite, component by component Started this topic · Evidence › Journal club · 7 Jul 2024 · 0 likes On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Reading FLOW ( N Engl J Med ,…
The mass-error checker and its intended scope Replied, post #76 · Data & Tools › Calculators · 26 Jun 2024 · 6 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way. Not the whole picture,…